Private Trust Co. NA cut its stake in shares of Steris PLC (NYSE:STE) by 13.1% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,334 shares of the medical equipment provider’s stock after selling 806 shares during the period. Private Trust Co. NA’s holdings in Steris were worth $560,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of STE. Victory Capital Management Inc. purchased a new stake in Steris during the 1st quarter valued at approximately $114,441,000. Robeco Institutional Asset Management B.V. purchased a new stake in Steris during the 1st quarter valued at approximately $50,730,000. BlackRock Inc. raised its stake in Steris by 4.1% during the 1st quarter. BlackRock Inc. now owns 7,476,972 shares of the medical equipment provider’s stock valued at $698,051,000 after acquiring an additional 292,563 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in Steris by 8.4% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,164,389 shares of the medical equipment provider’s stock valued at $202,068,000 after acquiring an additional 168,528 shares during the last quarter. Finally, Prudential Financial Inc. raised its stake in Steris by 45.3% during the 1st quarter. Prudential Financial Inc. now owns 496,930 shares of the medical equipment provider’s stock valued at $46,393,000 after acquiring an additional 154,866 shares during the last quarter. 90.70% of the stock is owned by hedge funds and other institutional investors.

Separately, Zacks Investment Research downgraded Steris from a “buy” rating to a “hold” rating in a research note on Wednesday, March 28th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Steris currently has an average rating of “Buy” and a consensus price target of $87.80.

Shares of Steris opened at $106.27 on Wednesday, MarketBeat.com reports. The company has a market cap of $8.89 billion, a PE ratio of 25.61 and a beta of 1.10. Steris PLC has a 12-month low of $80.74 and a 12-month high of $107.97. The company has a quick ratio of 1.97, a current ratio of 2.48 and a debt-to-equity ratio of 0.41.

Steris (NYSE:STE) last issued its earnings results on Wednesday, May 9th. The medical equipment provider reported $1.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.02. The business had revenue of $716.00 million during the quarter, compared to the consensus estimate of $703.37 million. Steris had a return on equity of 11.55% and a net margin of 11.10%. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.11 EPS. equities research analysts expect that Steris PLC will post 4.71 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 28th. Stockholders of record on Friday, June 8th were paid a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date was Thursday, June 7th. Steris’s dividend payout ratio (DPR) is 29.88%.

In related news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 9th. The stock was sold at an average price of $100.50, for a total value of $1,005,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Sudhir K. Pahwa sold 1,981 shares of the company’s stock in a transaction that occurred on Wednesday, April 18th. The stock was sold at an average price of $97.11, for a total value of $192,374.91. The disclosure for this sale can be found here. Over the last three months, insiders have sold 55,395 shares of company stock valued at $5,698,019. Company insiders own 2.38% of the company’s stock.

Steris Profile

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.